Global Healthcare CMO Market to Reach US$246.5 bn by 2019, Asia Pacific to Report Highest Growth

Transparency Market Research presents this most up-to-date research on "Healthcare CMO Market Pharmaceutical Contract Manufacturing (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Formulations (FDF) Manufacturing and Packaging) & Medical Device Contract Manufacturing (Design Outsourcing, Device Manufacturing & Final Goods Assembly) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019"

Contract manufacturing outsourcing (CMO) involves outsourcing of certain manufacturing activities that were previously performed by the producer to a third-party. It is an emerging trend in the global healthcare industry. Nowadays, most of the medical and pharmaceutical devices manufacturers are outsourcing production activities to contract manufacturers in order to reduce production cost without compromising on the product quality or to achieve expertise in a specific business segment, which is not available in-house.

According to the report, the presence of a skilled workforce at a low price in emerging economies has encouraged companies involved in the production of medical and pharmaceutical devices to outsource certain manufacturing activities, propelling the global healthcare CMO market significantly. The restructuring of manufacturing procedures and other activities involved in the production of medical and pharmaceutical devices has also strengthened the contract manufacturing outsourcing trend in the global healthcare industry.

The report analyzes the global healthcare CMO market on the basis of the type of service and the regional spread of this market. Based on the service type, the market has been broadly classified into pharmaceutical CMO services and medical device CMO services. The pharmaceutical CMO services segment dominated the global market with a share of 55.4% in 2012.

View Full Report at : http://www.transparencymarketresearch.com/healthcare-cmo-market.html

The global healthcare CMO market is segmented into pharmaceutical contract manufacturing services and medical devices contract manufacturing services. Further, the pharmaceutical contract manufacturing services segment is classified as API (active pharmaceutical ingredients) manufacturing, FDF (final dosage formulations) manufacturing and packaging. Among these, contract FDF manufacturing segment is expected to experience a healthy growth rate during the forecast period of 2013 to 2019, due to the rise demand for generic drugs and increasing R&D investment by life sciences companies. In addition, rise in number of blockbuster drugs going off-patent and increased adoption of novel technologies are further boosting the growth of this market. Similarly, medical devices contract manufacturing services segment is further categorized into design outsourcing, device manufacturing and final goods assembly. Among these afore-mentioned services, the market for medical device contract manufacturing accounted for largest market share (87.7%) in 2012 and is expected to grow at an attractive growth rate during the forecast period of 2013 to 2019.

Geographically, North America constituted the largest market in the global healthcare CMO market in 2012; however, Asia-Pacific is predicted to foresee the highest growth rate of 17.8% from 2013 to 2019. This growth has been attributed to favorable government regulations, improved intellectual property protection rights and increased adoption of novel technologies. In addition, tax benefits, low labor costs and other overheads and availability of skilled professionals at a very low cost compared to developed nations would trigger the growth of this market in Asia-Pacific region.

The major players of this market are Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Lonza Group, Patheon, Inc., Piramal Healthcare, Accellent, Symmetry Medical, Inc., Greatbatch, Inc., Memry Corporation, Teleflex MedOEM, Admedes Schuessler and Donatelle.

Download Sample Copy of Report at :

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2452

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

This release was published on openPR.